Your browser doesn't support javascript.
loading
Inhibition of NMDA Receptor Activation in the Rostral Ventrolateral Medulla by Amyloid-ß Peptide in Rats.
Islam, Md Sharyful; Lai, Chih-Chia; Wang, Lan-Hui; Lin, Hsun-Hsun.
Afiliación
  • Islam MS; Master and Ph.D. Programs in Pharmacology and Toxicology, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan.
  • Lai CC; Department of Pharmacology, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan.
  • Wang LH; Department of Pharmacy, Buddhist Tzu Chi General Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan.
  • Lin HH; Department of Physiology, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan.
Biomolecules ; 13(12)2023 12 02.
Article en En | MEDLINE | ID: mdl-38136607
ABSTRACT
N-methyl-D-aspartate (NMDA) receptors, a subtype of ionotropic glutamate receptors, are important in regulating sympathetic tone and cardiovascular function in the rostral ventrolateral medulla (RVLM). Amyloid-beta peptide (Aß) is linked to the pathogenesis of Alzheimer's disease (AD). Cerebro- and cardiovascular diseases might be the risk factors for developing AD. The present study examines the acute effects of soluble Aß on the function of NMDA receptors in rats RVLM. We used the magnitude of increases in the blood pressure (pressor responses) induced by microinjection of NMDA into the RVLM as an index of NMDA receptor function in the RVLM. Soluble Aß was applied by intracerebroventricular (ICV) injection. Aß1-40 at a lower dose (0.2 nmol) caused a slight reduction, and a higher dose (2 nmol) showed a significant decrease in NMDA-induced pressor responses 10 min after administration. ICV injection of Aß1-42 (2 nmol) did not affect NMDA-induced pressor responses in the RVLM. Co-administration of Aß1-40 with ifenprodil or memantine blocked the inhibitory effects of Aß1-40. Immunohistochemistry analysis showed a significant increase in the immunoreactivity of phosphoserine 1480 of GluN2B subunits (pGluN2B-serine1480) in the neuron of the RVLM without significant changes in phosphoserine 896 of GluN1 subunits (pGluN1-serine896), GluN1 and GluN2B, 10 min following Aß1-40 administration compared with saline. Interestingly, we found a much higher level of Aß1-40 compared to that of Aß1-42 in the cerebrospinal fluid (CSF) measured using enzyme-linked immunosorbent assay 10 min following ICV administration of the same dose (2 nmol) of the peptides. In conclusion, the results suggest that ICV Aß1-40, but not Aß1-42, produced an inhibitory effect on NMDA receptor function in the RVLM, which might result from changes in pGluN2B-serine1480 (regulated by casein kinase II). The different elimination of the peptides in the CSF might contribute to the differential effects of Aß1-40 and Aß1-42 on NMDA receptor function.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: N-Metilaspartato / Receptores de N-Metil-D-Aspartato Límite: Animals Idioma: En Revista: Biomolecules Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: N-Metilaspartato / Receptores de N-Metil-D-Aspartato Límite: Animals Idioma: En Revista: Biomolecules Año: 2023 Tipo del documento: Article País de afiliación: Taiwán